MeSH definition : A tissue plasminogen activator enzyme that acts as a fibrinolytic agent; it is used
for the dissolution of blood clots, such as those that occur in acute MYOCARDIAL INFARCTION.;
A tissue plasminogen activator enzyme that acts as a fibrinolytic agent; it is used
for the dissolution of blood clots, such as those that occur in acute MYOCARDIAL INFARCTION.
https://www.ema.europa.eu/medicines/human/EPAR/Metalyse 2024 false United Kingdom French English syndication feed Acute cerebrovascular accident due to ischemia (disorder) Ischemic Stroke myocardial infarction thrombolytic therapy tissue plasminogen activator tissue plasminogen activator tissue plasminogen activator tissue plasminogen activator fibrinolytic agents fibrinolytic agents fibrinolytic agents fibrinolytic agents treatment outcome drug evaluation injections, intravenous tenecteplase tissue plasminogen activator drug evaluation summary of product characteristics package leaflet tissue plasminogen activator Tenecteplase Tenecteplase
--- https://www.has-sante.fr/jcms/p_3563532/fr/metalyse-tenecteplase-avc-ischemique 2024 false false false France insurance, health, reimbursement treatment outcome tenecteplase fibrinolytic agents adult Product containing only tenecteplase in parenteral dose form (medicinal product form) evaluation of the transparency committee Tenecteplase Ischemic Stroke
--- https://www.cadth.ca/sites/default/files/pdf/138_tenecteplase_cetap_f.pdf https://www.cadth.ca/sites/default/files/pdf/138_tenecteplase_cetap_e.pdf 2001 Canada French English fibrinolytic agents myocardial infarction treatment outcome tissue plasminogen activator canada Evidence-Based medicine injections, intravenous acute disease clinical trials as topic tissue plasminogen activator fibrinolytic agents drug costs fibrinolytic agents tissue plasminogen activator tenecteplase tissue plasminogen activator drug evaluation bibliography Tenecteplase Tenecteplase Tenecteplase